CDX2 as a Prognostic Biomarker in Colon Cancer REPLY

被引：0
作者：
Dalerba, Piero [1 ]
Sahoo, Debashis [2 ]
Clarke, Michael F. [3 ]
机构：
[1] Columbia Univ, New York, NY USA
[2] Univ Calif San Diego, San Diego, CA 92103 USA
[3] Stanford Univ, Stanford, CA 94305 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2016年 / 374卷 / 22期
关键词：
COLORECTAL-CANCER; EXPRESSION;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2184 / 2184
页数：1
相关论文
共 50 条
  • [21] Combination of CDX2 expression and T stage improves prognostic prediction of colorectal cancer
    Xu, Weimin
    Zhu, Yilian
    Shen, Wei
    Ding, Wenjun
    Wu, Tingyu
    Guo, Yuegui
    Chen, Xiaobing
    Zhou, Mingxia
    Chen, Yingwei
    Cui, Long
    Du, Peng
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (05) : 1829 - 1842
  • [22] Prognostic significance of CDX2 immunoexpression in poorly differentiated clusters of colorectal carcinoma
    Bonetti, Luca Reggiani
    Lionti, Simona
    Vitarelli, Enrica
    Barresi, Valeria
    VIRCHOWS ARCHIV, 2017, 471 (06) : 731 - 741
  • [23] Targeted CDX2 expression inhibits aggressive phenotypes of colon cancer cells in vitro and in vivo
    Zheng, Jianbao
    He, Sai
    Qi, Jie
    Wang, Xiaolong
    Yu, Junhui
    Wu, Yunhua
    Gao, Qi
    Wang, Kai
    Sun, Xuejun
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 51 (02) : 478 - 488
  • [24] Primary adenocarcinoma of colon: A clinicopathological study with the prevalence and correlation of CDX2 biomarker expression - A tertiary care center experience
    Issac, Rijo
    Masih, Dipti
    Ranjan, Mark
    Pulimood, Anna B.
    INDIAN JOURNAL OF CANCER, 2024, 61 (02) : 238 - 243
  • [25] Reactivation of CDX2 in Gastric Cancer as Mark for Gene Silencing Memory
    Kameoka, Yuri
    Kitazawa, Riko
    Ariasu, Kanazu
    Tachibana, Ryosuke
    Mizuno, Yosuke
    Haraguchi, Ryuma
    Kitazawa, Sohei
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 2015, 48 (04) : 115 - 124
  • [26] CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
    Aasebo, Kristine
    Dragomir, Anca
    Sundstrom, Magnus
    Mezheyeuski, Artur
    Edqvist, Per-Henrik
    Eide, Geir Egil
    Ponten, Fredrik
    Pfeiffer, Per
    Glimelius, Bengt
    Sorbye, Halfdan
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [27] Regulation of APC and AXIN2 expression by intestinal tumor suppressor CDX2 in colon cancer cells
    Olsen, Anders Kruger
    Coskun, Mehmet
    Bzorek, Michael
    Kristensen, Michael Holmsgaard
    Danielsen, Erik Thomas
    Jorgensen, Steffen
    Olsen, Jorgen
    Engel, Ulla
    Holck, Susanne
    Troelsen, Jesper Thorvald
    CARCINOGENESIS, 2013, 34 (06) : 1361 - 1369
  • [28] CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway
    Graule, Janina
    Uth, Kristin
    Fischer, Elia
    Centeno, Irene
    Galvan, Jose A.
    Eichmann, Micha
    Rau, Tilman T.
    Langer, Rupert
    Dawson, Heather
    Nitsche, Ulrich
    Traeger, Peter
    Berger, Martin D.
    Schnuriger, Beat
    Hadrich, Marion
    Studer, Peter
    Inderbitzin, Daniel
    Lugli, Alessandro
    Tschan, Mario P.
    Zlobec, Inti
    CLINICAL EPIGENETICS, 2018, 10 : 120
  • [29] CDX2 as a Predictive Biomarker Involved in Immunotherapy Response Suppresses Metastasis through EMT in Colorectal Cancer
    Wang, Yun-shuai
    Kou, Yu
    Zhu, Ren-tao
    Han, Bao-wei
    Li, Chao-hui
    Wang, Huang-jian
    Wu, Hui-bin
    Xia, Tian-ming
    Che, Xiang-ming
    DISEASE MARKERS, 2022, 2022
  • [30] CDX2 expression and perioperative patient serum affects the adhesion properties of cultured colon cancer cells
    Davidsen, Johanne
    Jessen, Stine Bull
    Watt, Sara Kehlet
    Larsen, Sylvester
    Dahlgaard, Katja
    Kirkegaard, Tove
    Gogenur, Ismail
    Troelsen, Jesper T.
    BMC CANCER, 2020, 20 (01)
12345